Scientists' hands at work

Advancing Clinical and Translational Science

N.C. A&T is partnering with the University of North Carolina at Chapel Hill and RTI International in the North CarolinTranslational and Clinical Sciences (NC TraCS) Institute.

The latest NC TraCS news

The mission of NC TraCS is to accelerate clinical and translational research from health science to discovery to dissemination to patients and communities. It seeks to overcome barriers to translation by improving efficiency, training the research workforce and sharing successful research methods.

NC TraCS aims to: 

  • Expand to support the full spectrum of clinical and translational research.
  • Focus on three strategic initiatives: next-generation technologies to transform clinical research and practice, new paradigms and resources to accelerate drug development, and comparative-effectiveness research to provide definitive evidence of the benefits and harms of tests and treatments.
  • Train, support and motivate the next generation of clinical and translational researchers.

CTSA logoNC TraCS is the integrated home of the Clinical and Translational Science Awards (CTSA) program at UNC-CH. It is supported through the National Institutes of Health (NIH), grant 1UL1TR001111. The CTSA program is led by the NIH’s National Center for Advancing Translational Sciences (NCATS).

Release time for proposal development in Spring 2015

The Division of Research and Economic Development (DORED) is offering this Proposal Development Opportunity (“PDO” or “opportunity”) for N.C. A&T faculty members. This PDO is designed to support NC A&T faculty efforts to prepare well-written, innovative, and strategic proposals relevant to health science. The PDO will provide faculty release time from one class during the Spring 2015 semester to develop a proposal in the health science area in response to a solicitation from an external sponsor. The number of faculty members receiving funding via this opportunity will be limited only by the quality of proposals submitted by the imminent deadline.

Proposals are due Monday November 17. Awards will be announced Friday November 21. Click here for details.

Initial A&T projects: Triple-negative breast cancer and COPD

Two projects led by A&T researchers have been funded.

Improving biomedical research

The NC TraCS Institute is one of 62 CTSA medical research institutions, a national consortium to improve the way biomedical research is conducted across the country.

The partnership with A&T gives UNC researchers access to the state-of-the-art laboratories at the Joint School of Nanoscience and Nanoengineering, while providing N.C. A&T faculty collaborative opportunities and financial resources to accelerate discoveries in the lab to patients, particularly those from underrepresented minorities.

“Together, we will develop a robust pipeline of minority clinical and translational research scientists in a manner that can be a model for the nation,” said Dr. Barry L. Burks, N.C. A&T’s Vice Chancellor for Research and Economic Development.

Fostering team science

Launched in 2006, the NIH-led CTSA program has enabled innovative research teams to speed discovery and advance science aimed at improving the nation’s health. Institutional CTSA awards are at the centerpiece of the program, providing academic homes for translational sciences. The program currently supports a consortium of approximately 60 academic medical institutions that is fostering team science, leveraging national resources and transforming the way biomedical research is conducted across the country.

“The goal and mission of NC TraCS will continue to enable investigators, research units and academic programs to be even more successful in making lives better in our state’s communities,” said Marschall S. Runge, principal investigator of the CTSA at UNC, and executive dean for the School of Medicine.